Home | Welcome to Contract Pharma   
Last Updated Wednesday, September 17 2014
Print

Search Results for 'Financial Report: BASi'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published August 14, 2014
Service revenues up 14% in the quarter Read More »
By Kristin Brooks
Published February 13, 2014
Revenues up 7% in the quarter driven by Culex sales Read More »
Published October 18, 2013
Returns to profitability in the quarter Read More »
Published May 15, 2013
Consolidation efforts impact results Read More »
Published December 28, 2012
Restructuring charges impacts results Read More »
Published August 14, 2012
Restructuring charges impact results Read More »
Published April 21, 2011
U.S. product sales in the quarter increased 4% to $2.8 billion. Read More »
Published December 29, 2010
Revenues down, but improving in 2H10 Read More »
By Michael Martorelli
Published November 6, 2009
Feel Better Now? Ending one year, approaching the next By Michael A. Martorelli It’s always interesting to write a column about an event that is still in my future, but will have already happened by the time you read my words. Th… Read More »
Published February 8, 2007
BASi 1Q Revenues: $10.9 million (+11%) 1Q Earnings: $556,000 (loss of $716,000 1Q2006) Comments: Bioanalytical and toxicology operations revenues increased in the quarter, revenues from product sales were flat, and revenues from clinical… Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On